SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 10.33   0.76 (+7.94%) Volume: 467.23k 4:00 PM EDT 18-Sep-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)708/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)10308/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals1808/12/2020
S-3Registration statement under Securities Act of 19338808/07/2020
<<
First
<
Prev
123456789101112131415